Sites and investigators
Bring a qualified investigator, suitable patients, governing-body approval, and readiness to meet the protocol’s requirements.
ACCESS Research
Clinical research for outpatient EP surgery centers.
ACCESS Research is developing a site management organization for outpatient EP. The Registry provides the data foundation; the SMO model supplies the shared study support that individual ASCs may not have.
The SMO model
Support for the site’s research work
An SMO supports the participating site with study startup, coordination, regulatory work, and data operations. The center retains its patients and principal-investigator responsibilities.
ACCESS’s proposed network model brings sponsor discussions and study feasibility together, then matches studies to sites based on capability, patient population, investigator qualifications, performance, capacity, and study requirements.
Sponsors and CROs
Bring protocols suited to the outpatient setting and discuss network feasibility and site requirements.
Program status
What was operational at the August launch
Operational
Study feasibility using Registry data was described as operational on August 23, 2026.
In development
Central contracting, central IRB support, coordinators, CTMS, and monitoring were explicitly described as in build.
The SMO is developing. Contact ACCESS to confirm current service availability and the arrangements required to activate your site.
MANIFEST-ASC
The first announced network study
At the August 23, 2026 webinar, MANIFEST-ASC was announced as approved, funded, and open to ACCESS network sites.
The described study is prospective, multicenter, non-randomized, and observational, examining consecutive AF ablation procedures in U.S. ASCs.
Target
1,000 consecutive AF ablation procedures across network sites.
Measures
Safety, acute procedural success, efficiency, utilization, and cross-site benchmarking.
Window
A two-year enrollment and follow-up window was described in the presentation.
These are the announced design and target, not completed enrollment or published results. Ask ACCESS about current site eligibility and study status.
Site readiness
Registry participation supports the next step
The research pathway begins with reliable case submission. Study participation also requires appropriate site capabilities, a qualified investigator, governing-body approval, and study-specific review and activation.
Suitable case selection and emergency arrangements remain essential. A Registry account alone does not make a center an activated trial site.
Start with the Registry ↗Bring the questions worth answering
Investigators can discuss their center’s readiness. Sponsors can discuss protocols and the evidence they need from outpatient EP.
Contact ACCESS